Capstone Triton Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
+8,324
| New | +$1.55M | 1.12% | 31 |
|
|
2024
Q4 | $1.4M | Buy |
7,889
+4
| +0.1% | +$711 | 0.88% | 39 |
|
|
2024
Q3 | $1.56M | Sell |
7,885
-199
| -2% | -$39.3K | 1% | 33 |
|
|
2024
Q2 | $1.39M | Sell |
8,084
-55
| -0.7% | -$9.43K | 0.97% | 33 |
|
|
2024
Q1 | $1.48M | Buy |
8,139
+152
| +2% | +$27.7K | 1.05% | 33 |
|
|
2023
Q4 | $1.24M | Sell |
7,987
-718
| -8% | -$111K | 0.9% | 37 |
|
|
2023
Q3 | $1.3M | Buy |
8,705
+104
| +1% | +$15.5K | 0.95% | 37 |
|
|
2023
Q2 | $1.16M | Buy |
8,601
+223
| +3% | +$30K | 0.8% | 46 |
|
|
2023
Q1 | $1.34M | Buy |
8,378
+489
| +6% | +$77.9K | 1% | 36 |
|
|
2022
Q4 | $1.27M | Buy |
7,889
+627
| +9% | +$101K | 1.02% | 35 |
|
|
2022
Q3 | $975K | Buy |
7,262
+205
| +3% | +$27.5K | 0.83% | 43 |
|
|
2022
Q2 | $1.04M | Buy |
7,057
+277
| +4% | +$40.9K | 0.79% | 44 |
|
|
2022
Q1 | $1.07M | Buy |
6,780
+475
| +8% | +$74.9K | 0.75% | 41 |
|
|
2021
Q4 | $857K | Buy |
6,305
+623
| +11% | +$84.7K | 1.73% | 14 |
|
|
2021
Q3 | $617K | Buy |
5,682
+969
| +21% | +$105K | 0.37% | 67 |
|
|
2021
Q2 | $531K | Buy |
4,713
+610
| +15% | +$68.7K | 0.33% | 67 |
|
|
2021
Q1 | $444K | Buy |
4,103
+128
| +3% | +$13.9K | 0.29% | 66 |
|
|
2020
Q4 | $426K | Buy |
+3,975
| New | +$426K | 0.26% | 60 |
|